Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.730
-0.030 (-1.70%)
At close: Dec 5, 2025, 4:00 PM EST
1.720
-0.010 (-0.58%)
After-hours: Dec 5, 2025, 7:57 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $152.71 million as of December 5, 2025. Its market cap has increased by 694.38% in one year.
Market Cap
152.71M
Enterprise Value
113.76M
1-Year Change
694.38%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $152.71M, a decrease of -40.45%. That is a compound annual growth rate of -11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 155.36M | 433.20% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |